Li Q, Yokoyama S
Department of Medicine, University of Alberta, Edmonton, Canada.
J Biol Chem. 1995 Nov 3;270(44):26216-23. doi: 10.1074/jbc.270.44.26216.
Cholesterol was poorly available to free apolipoprotein (apo)A-I-mediated cellular lipid efflux from cholesterol-loaded rat vascular smooth muscle cells generating cholesterol-poorer pre-beta-HDL particles than those generated from macrophages by the same reaction (Li, Q., Komaba, A., and Yokoyama, S. (1993) Biochemistry 32, 4597-4603). The factors known to induce transformation of the smooth muscle cells into a macrophage-like stage were used in order to modulate this reaction, such as human platelet-derived growth factor, macrophage colony-stimulating factor, and phorbol 12-myristate-13-acetate (PMA). When the cells were stimulated by PMA following the pretreatment with platelet-derived growth factor plus macrophage colony-stimulating factor, cholesterol efflux mediated by free apoA-I increased 3-fold without changing phospholipid efflux, resulting in generation of pre-beta-HDL particles more rich in cholesterol. This treatment had only a little or no effect on apparent cellular cholesterol efflux to HDL or lipid microemulsion, respectively. Overall cellular free cholesterol pool size was unaffected by the treatment, and probing by extracellular cholesterol oxidase did not detect gross change in the cellular surface cholesterol. This specific enrichment of cholesterol in the apoA-I-mediated cellular lipid efflux was reversed by protein kinase C inhibitors. Measurement of intracellular cholesterol esterification suggested that PMA induced translocation of intracellular cholesterol to a specific pool for apoA-I-mediated efflux, and a protein kinase C inhibitor reversed this effect.
游离载脂蛋白(apo)A-I介导的细胞脂质外流难以从胆固醇负荷的大鼠血管平滑肌细胞中获取胆固醇,所产生的前β-HDL颗粒的胆固醇含量低于相同反应条件下巨噬细胞产生的前β-HDL颗粒(Li,Q.,Komaba,A.,和Yokoyama,S.(1993年)《生物化学》32卷,4597 - 4603页)。为了调节这种反应,使用了已知能诱导平滑肌细胞转化为巨噬细胞样阶段的因子,如人血小板衍生生长因子、巨噬细胞集落刺激因子和佛波醇12 - 肉豆蔻酸酯 - 13 - 乙酸酯(PMA)。当细胞先用血小板衍生生长因子加巨噬细胞集落刺激因子预处理后再用PMA刺激时,游离apoA-I介导的胆固醇外流增加了3倍,而磷脂外流不变,从而产生了胆固醇含量更高的前β-HDL颗粒。这种处理分别对细胞向HDL或脂质微乳液的表观胆固醇外流只有很小的影响或没有影响。细胞内总游离胆固醇池大小不受该处理的影响,细胞外胆固醇氧化酶检测未发现细胞表面胆固醇有明显变化。蛋白激酶C抑制剂可逆转apoA-I介导的细胞脂质外流中胆固醇的这种特异性富集。细胞内胆固醇酯化的测量表明,PMA诱导细胞内胆固醇转运至apoA-I介导的外流的特定池,而蛋白激酶C抑制剂可逆转这种作用。